TY - JOUR
T1 - Paeonol inhibits profibrotic signaling and HOTAIR expression in fibrotic buccal mucosal fibroblasts
AU - Ho, Dennis Chun Yu
AU - Chen, Szu Han
AU - Fang, Chih Yuan
AU - Hsieh, Chang Wei
AU - Hsieh, Pei Ling
AU - Liao, Yi Wen
AU - Yu, Cheng Chia
AU - Tsai, Lo Lin
N1 - Funding Information:
This work is supported by Wan Fang Hospital ( 110-phd-05 ) and National Chung Hsing University and Chung Shan Medical University ( NCHU-CSMU10909 ) in Taiwan.
Publisher Copyright:
© 2021
PY - 2022/5
Y1 - 2022/5
N2 - Background/purpose: Betel nut chewing is the major risk factor of oral submucous fibrosis (OSF). Various studies have sought to discover alternative strategies to alleviate oral fibrogenesis. In the present study, we aimed to evaluate the anti-fibrosis effect of paeonol, a phenolic component derived from Paeonia Suffruticosa. Methods: The cytotoxicity of paeonol was tested using normal and fibrotic buccal mucosal fibroblasts (fBMFs) derived from OSF tissues. Collagen gel contraction, Transwell migration, invasion, and wound healing capacities were examined. Besides, the activation of TGF-β/Smad2 signaling and expression levels of type I collagen, α-SMA, and long non-coding RNA HOTAIR were measured as well. Results: Paeonol exerted a higher cytotoxic effect on fBMFs compared to normal BMFs. The arecoline-induced myofibroblast activities, including collagen gel contractility, cell motility, and wound healing ability were all suppressed by paeonol treatment. In addition, the activation of the TGF-β/Smad2 pathway was inhibited along with a lower expression of α-SMA and type I collagen in paeonol-treated cells. Also, the administration of paeonol decreased the mRNA expression of HOTAIR in fBMFs. Conclusion: Our results indicate that paeonol may be a promising compound to attenuate the progression of oral fibrogenesis in OSF patients.
AB - Background/purpose: Betel nut chewing is the major risk factor of oral submucous fibrosis (OSF). Various studies have sought to discover alternative strategies to alleviate oral fibrogenesis. In the present study, we aimed to evaluate the anti-fibrosis effect of paeonol, a phenolic component derived from Paeonia Suffruticosa. Methods: The cytotoxicity of paeonol was tested using normal and fibrotic buccal mucosal fibroblasts (fBMFs) derived from OSF tissues. Collagen gel contraction, Transwell migration, invasion, and wound healing capacities were examined. Besides, the activation of TGF-β/Smad2 signaling and expression levels of type I collagen, α-SMA, and long non-coding RNA HOTAIR were measured as well. Results: Paeonol exerted a higher cytotoxic effect on fBMFs compared to normal BMFs. The arecoline-induced myofibroblast activities, including collagen gel contractility, cell motility, and wound healing ability were all suppressed by paeonol treatment. In addition, the activation of the TGF-β/Smad2 pathway was inhibited along with a lower expression of α-SMA and type I collagen in paeonol-treated cells. Also, the administration of paeonol decreased the mRNA expression of HOTAIR in fBMFs. Conclusion: Our results indicate that paeonol may be a promising compound to attenuate the progression of oral fibrogenesis in OSF patients.
KW - Buccal mucosal fibroblasts
KW - Oral submucous fibrosis
KW - Paeonol
UR - http://www.scopus.com/inward/record.url?scp=85117864971&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117864971&partnerID=8YFLogxK
U2 - 10.1016/j.jfma.2021.09.027
DO - 10.1016/j.jfma.2021.09.027
M3 - Article
AN - SCOPUS:85117864971
SN - 0929-6646
VL - 121
SP - 930
EP - 935
JO - Journal of the Formosan Medical Association
JF - Journal of the Formosan Medical Association
IS - 5
ER -